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ABSTRACT
Human mucormycosis is an atypical fungal infection that commonly affects the skin, 
but rarely the auricular region. A 32-year-old diabetic woman, agricultural worker, 
was admitted with swelling, redness and mild signs of epidermolysis of the left ear, 
associated with intense pain, facial paralysis and septic signs. The ear cellulitis 
evolved into necrosis of the same region on the following day. Surgical debridement 
was performed and antimycotic therapy was started with poor response. The patient 
died in 48h. Culture was confirmatory for Rhizopus sp.
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Mucormycosis is a rare but aggressive fungal infection, which occurs most 
often among patients with diabetes mellitus and other immunosuppressed 
individuals1. Most cases are associated to Rhizopus sp, a genus of common 
saprophytic fungi on plants and decaying organic matter. Most human infections 
are rhinocerebral and sinopulmonary. Cutaneous mucormycosis are also 
frequent and generally result from direct inoculation of fungal spores in the 
skin through any kind of injury, causing tissue necrosis by angioinvasion. 
The authors reported a case of a 32-year-old diabetic woman, agricultural 
worker, admitted to this service with a fulminant auricular mucormycosis.
CASE REPORT
A 32-year-old female patient from the public health system, with 
type 1 diabetes not adequately managed, was admitted to the author’s service 
with pain on the left ear and tachypnea for 2 to 3 days. She reported a story 
of periauricular wounds about two days after the onset of the symptoms. 
She was an agricultural worker in the tobacco industry, and had been engaged 
in cleaning tobacco leaf stitching machines in the previous days. On clinical 
examination, a peripheral ipsilateral facial palsy was present. There was 
swelling, redness and mild signs of epidermolysis of the left ear, associated 
with intense pain, respiratory frequency of 25bpm and heart rate of 105 bpm. 
There was no fever. A significant ear canal edema made it impossible to perform 
a satisfactory otoscopy. The serum glucose level on arrival was 350 mg/dL. 
The first clinical hypothesis was a malignant external otitis caused by Herpes 
Zoster or bacterial infection. A 24-hour scheme of intravenous acyclovir and 
antibiotics was introduced. Clinical management for decompensated diabetes 
was also performed. In 24 hours, the patient got worse. Fever was present. 
The left auricular region started to show necrotic signs and she required 
intensive care for respiratory and hemodynamic support. The cranial CT showed 
no signs of fasciitis, mastoiditis or damage to the central nervous system. 
In few hours, the necrotic area of the ear became larger (Figure 1) and an 
urgent extensive debridement was performed, including ear amputation and 
resection of peripheral soft tissues. During the surgical procedure, there were 
signs of arterial and venous thrombosis and extensive gangrene of tissues, 
without purulent secretion. Mucormycosis was suspected and liposomal 
amphotericin B was introduced. It was observed a mild clinical improvement 
after 6 hours of antifungal administration. However, on the following day, 
there were signs of mold growing on the surgical bed and an enlargement of 
the necrotic area (Figure 2). The gangrene area involved nearly half of the 
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patient’s face, including oral cavity and the left eye 
globe. Clinical parameters got worse. The patient’s 
family did not authorize a new debridement and brain 
death diagnosis was established after 48 hours. 
Culture was confirmatory for Rhizopus sp (Figure 3).
DISCUSSION
Mucormycosis is known as a rare disease, 
more prevalent among adults and men. However, 
it is becoming more frequent, being the third most 
common invasive mycosis in order of importance, 
after Candidiasis and Aspergillosis, in patients 
with hematological and allogeneic stem cell 
transplantation1,2. It is mostly seen among patients 
with diabetes mellitus (36-88%), individuals 
immunosuppressed by chemotherapy or allogeneic 
stem cell transplants, and patients suffering from 
different kinds of physical traumas1. Although 
with some differences in fungal classes involved 
in human infections, the terms mucormycosis, 
zygomycosis and phycomycosis are commonly 
used interchangeably1.
Mucorales fungi cause most cases of human 
mucormycosis, and the species of genus Rhizopus 
is found in over 80% of mucormycoses2. Rhizopus 
is a genus of common saprophytic fungi on plants 
and some parasites. They are often isolated from 
soil, decaying organic material and fruits, but 
can also be found on vegetables, jellies, syrups, 
leather, bread, peanuts, and tobacco3. They are 
thermotolerant, although they usually prefer a 
humid and warm environment1.
Most human infections are rhinocerebral 
and sinopulmonary, generally a result of fungal 
inhalation. Cutaneous mucormycosis results from 
Figure 1: Preoperative appearance (about 24h after 
initial presentation). Note the large necrotic area around 
the left ear.
Figure 2: A day after surgical debridement. Note the signs 
of mold growing on the surgical bed and the enlargement 
of the necrotic area.
Figure 3: Rhizopus sp micromorphology. View from slide 
culture (40x). Note the presence and orientation of rhizoids.
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direct inoculation of fungal spores in the skin. 
These fungal species are vasotropic, causing 
tissue necrosis by angioinvasion and subsequent 
thrombosis. They begin usually at the site of 
penetration, following some injury. Although in this 
reported case the patient could not recall a history 
of trauma, other cutaneous mucormycosis were 
also reported secondary to minor injuries. In this 
particular case, the history of activity in tobacco 
culture draws attention, especially the fact of having 
cleaned tobacco leaf stitching machines recently.
According to the extent of the infection, cutaneous 
mucormycosis are classified as localized (affecting 
only the skin or subcutaneous tissue); deep (affecting 
muscles, tendons, or bone); and disseminated 
(affecting other noncontiguous organs). Its onset 
may be gradual and slow, or fulminant, leading 
to gangrene and hematogenous dissemination. 
The typical presentation of cutaneous mucormycosis 
is a necrotic eschar accompanied by surrounding 
erythema and induration. However, a disease 
spectrum ranging from a localized cutaneous 
wound to a disseminated and fatal infection may 
be seen, especially in immunocompromised hosts. 
In patients with opened wounds, lesions may have 
a cotton-like appearance, resembling that of bread 
mold (See Figure 3)4,5. Differential diagnosis must 
be made with pyoderma gangrenosum, bacterial 
synergistic gangrene, or other infections produced 
by bacteria or other fungi1.
Cutaneous infections frequently occur in the 
limbs, usually as a dolorous erythematous to violet 
lesion, becoming necrotic, with discharge of a 
malodorous putrid and black exudate2. The observed 
auricular localization is exceptional6, and only 
other five confirmed cases6-10 were found in the 
literature. Tuzcu et al. described a fulminant case 
in a 17-year-old girl with diabetic ketoacidosis, 
septic signs and cellulitis of right external ear. 
A black necrotic scar on the same ear appeared 
also only on the day after the initial presentation.
The clinical diagnosis of mucormycosis 
is challenging. Patients are often treated 
presumptively as histological and microbiological 
proof is time-consuming1. Ideally, a deep and 
early biopsy, with direct microscopy, culture and 
histopathology, would optimize the outcomes. 
A superficial scraping may only show necrotic tissue. 
Identification is based on microscopy. Mucorales hyphae 
are short, about 5μm in width and 20-50 μm long, 
and non-septate. Another microscopic consideration 
is that hyphae generally have ramifications at 
90° angles. This feature is useful in histological 
examination and direct microscopy for differential 
diagnosis with Aspergillus spp and Fusarium spp.
In culture, they usually grow rapidly (3-5 days) at 
25-28 °C. Mucorales form hairy, wooly, gray-white 
colonies that fill the tubes and Petri plates. Identification 
is done based on micromorphological and biochemical 
criteria. In histology, inflammatory granulation 
tissue with edema, necrosis, polymorphonuclear 
cells and plasma cells, as well as thromboses 
and vessel infarction are seen. The hyphae have 
a propensity for invasion of the walls of veins and 
arteries. Thick, hyaline, coenocytic, branched 
hyphae can be visualized by the PAS, Gomori 
and Grocott stain2.
Recently some articles were published regarding 
the application of mass spectrometry procedure 
based on the detection of a serum disaccharide 
(MS-DS) in fungal infections. Regarding specifically 
mucormycosis, the new technique preceded the date 
of a definite diagnosis. Until this moment, none of 
the serological tests currently on the market were 
efficient for the diagnosis. Apparently MS-DS could 
fill this gap, improving the promptness of a clinical 
diagnosis of this high lethal condition11.
In most cases, the infection is rapidly progressive 
with high risk of death, especially if underlying risk 
factors (i.e., metabolic acidosis) are not corrected in 
time1. The mortality rate varies according to the site 
of infection, host and time of diagnosis. Treatment 
success depends on the condition of the patient, 
associated factors, and the promptness of the 
diagnosis. For cases with cutaneous involvement, 
aggressive debridement with removal of all necrotic 
areas, in combination with liposomal amphotericin 
B are the most effective treatments2. Although the 
antifungal susceptibility testing is only marginally 
recommended for guidance of the treatment of 
patients with this disease, it may differ between 
species. Amphotericin B is still considered the most 
active drug against most species of Mucorales. 
Nevertheless, posaconazole and more recently 
isavuconazole are currently strongly recommended 
as salvage treatments for patients with mucormycosis 
refractory to Amphotericin or those intolerant to 
this agent. Although data are fragmentary and 
restricted to the most common Mucorales species, 
combination of antifungal drugs may represent a 
promising therapeutic strategy, as treatment efficacy 
may be improved by the synergistic interaction of 
drugs with distinct targets of action12.
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